首页> 外文期刊>Endocrine >Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma
【24h】

Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma

机译:XIAP和P2X7 受体表达与甲状腺乳头状癌淋巴结转移的关系

获取原文
获取原文并翻译 | 示例
           

摘要

The expression of X-linked inhibitor of apoptosis (XIAP) and the P2X7 receptor were demonstrated in a variety of tumors. The purpose of the present study was to investigate the associations of XIAP and P2X7 receptor expression with the clinicopathological features of patients with papillary thyroid carcinoma (PTC). In this cross-sectional study, a total of 62 cases were examined, including 43 patients with PTCs and 19 with benign nodular goiters. XIAP and P2X7 receptor expression were examined by immunohistochemical methods on formalin-fixed, paraffin-embedded thyroid tissues. The staining intensity and extent were evaluated and scored using a semi-quantitative method. The immunohistochemical staining score integrating the intensity and extent of XIAP and P2X7 receptors in PTCs was higher than in nodular goiters. XIAP (OR: 5.6, 95% CI: 1.5–21.1, P = 0.009) and P2X7 receptor (OR: 6.1, 95% CI: 1.5–24.4, P = 0.007) expression were associated with lymph node metastasis in PTCs. In logistic regression analysis, P2X7 receptor expression, tumor size, and capsular infiltration were predictors for lymph node metastasis (P = 0.001). Our results suggested that XIAP and P2X7 receptor expression may predict the aggressiveness of PTC.
机译:X-连锁凋亡抑制剂(XIAP)和P2X7 受体在多种肿瘤中均有表达。本研究旨在探讨XIAP和P2X7 受体表达与甲状腺乳头状癌(PTC)患者临床病理特征的关系。在这项横断面研究中,共检查了62例病例,包括43例PTCs和19例良性结节性甲状腺肿。通过免疫组织化学方法检测福尔马林固定,石蜡包埋的甲状腺组织中的XIAP和P2X7 受体表达。使用半定量方法评估染色强度和程度并对其评分。 PTCs中的XIAP和P2X7 受体的强度和程度的免疫组化染色评分高于结节性甲状腺肿。 XIAP(OR:5.6,95%CI:1.5–21.1,P = 0.009)和P2X7 受体(OR:6.1,95%CI:1.5–24.4,P = 0.007)的表达与淋巴结转移有关。 PTC。在逻辑回归分析中,P2X7 受体表达,肿瘤大小和荚膜浸润是淋巴结转移的预测因素(P = 0.001)。结果提示,XIAP和P2X7 受体的表达可能预示着PTC的侵袭性。

著录项

  • 来源
    《Endocrine》 |2010年第2期|p.276-282|共7页
  • 作者单位

    Department of Endocrine and Metabolic Diseases, Shanghai Clinical Center For Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, 197 Rui-jin Er Road, Shanghai, 200025, People’s Republic of China;

    Department of Endocrine and Metabolic Diseases, Shanghai Clinical Center For Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, 197 Rui-jin Er Road, Shanghai, 200025, People’s Republic of China;

    Department of Endocrine and Metabolic Diseases, Shanghai Clinical Center For Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, 197 Rui-jin Er Road, Shanghai, 200025, People’s Republic of;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    XIAP; P2X7 receptor; Lymph node metastasis; Papillary thyroid carcinoma (PTC);

    机译:XIAP;P2X7受体;淋巴结转移;乳头状甲状腺癌(PTC);

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号